Source comparison
CJC-1295 No DAC vs With DAC: Administration Comparison
Half-Life ~30 minutes 6–8 days The DAC modification extends circulation time by binding to serum albumin, but some researchers prefer the No DAC version for controllable, pulsatile GH release Dosing Frequency 1–3 times daily Once weekly No DAC requires daily c
This comparison does not assign a generated winner or score.
- Half-Life
- ~30 minutes
- 6–8 days
- The DAC modification extends circulation time by binding to serum albumin, but some researchers prefer the No DAC version for controllable, pulsatile GH release
- Dosing Frequency
- 1–3 times daily
- Once weekly
- No DAC requires daily commitment but allows precise timing around meals, sleep, and training
- Typical Dose
- 100–200 mcg per injection
- 1–2 mg per week
- Per-injection doses are lower for No DAC, but cumulative weekly exposure is similar between variants
- GH Release Pattern
- Pulsatile (mimics natural secretion)
- Sustained elevation (non-physiological)
- Pulsatile patterns align with endogenous GH architecture; sustained elevation may downregulate pituitary responsiveness over time
- Research Applications
- Acute GH response studies, anabolic signaling, pulse-timing investigations
- Long-term IGF-1 elevation studies, convenience-focused protocols
- No DAC is preferred when timing precision and natural pulsatility matter; With DAC is chosen for extended exposure without frequent dosing
- The with-DAC variant isn't superior. It's a different tool. Researchers studying circadian GH patterns or post-exercise anabolic windows choose the No DAC version specifically because it allows timed interventions. The DAC-modified version creates steady-state plasma levels that don't reflect physiological GH secretion architecture.